16 Feb 2023
The GLP-1 analogue appetite suppressing drug Wegovy may soon be available to buy in UK chemists. Experts warn that the medicine does not treat the root of obesity, and that there are risks of regaining weight once the treatment is ceased.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024